Clinical management and outcome of refractory asthma in the UK from the British Thoracic Society Difficult Asthma Registry

Thorax

Volumn 67, Issue 8, 2012, Pages 754-756

  Sweeney, Joan ^a   Brightling, Chris E ^b   Menzies Gow, Andrew ^c   Niven, Robert ^d   Patterson, Chris C ^a   Heaney, Liam G ^a  

^a QUEEN'S UNIVERSITY BELFAST   (United Kingdom)

^b UNIVERSITY OF LEICESTER   (United Kingdom)

^c ROYAL BROMPTON AND HAREFIELD NHS FOUNDATION TRUST   (United Kingdom)

^d UNIVERSITY OF MANCHESTER   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOSTEROID; NITRIC OXIDE; OMALIZUMAB; STEROID;

ADULT; ARTICLE; ASTHMA; BODY MASS; COHORT ANALYSIS; DRUG DOSE REDUCTION; FEMALE; HEALTH CARE; HEALTH CARE DELIVERY; HOSPITAL ADMISSION; HUMAN; LUNG FUNCTION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; REFRACTORY ASTHMA; REGISTER; TREATMENT OUTCOME; UNITED KINGDOM;

EID: 84864003908     PISSN: 00406376     EISSN: 14683296     Source Type: Journal    
DOI: 10.1136/thoraxjnl-2012-201869     Document Type: Article

References (7)

1. Heaney LG, Brightling CE, Menzies-Gow A, et al. Refractory asthma in the UK: cross sectional findings from a UK multicentre registry. Thorax 2010;65:787-94.
2. Petsky HL, Cates CJ, Lasserson TJ, et al. A systematic review and meta-anslysis: tailoring asthma treatment on eosinophilic markers (exhaled nitric oxide or sputum eosinophils). Thorax 2012;67:199-208.
3. Hashimoto S, Brinke AT, Roldaan AC, et al. Internet-based tapering of oral corticosteroids in severe asthma: a pragmatic randomised controlled trial. Thorax 2011;66:514-20.
4. Heaney LG, Conway E, Kelly C, et al. Predictors of therapy resistant asthma: outcome of a systematic evaluation protocol. Thorax 2003;58:561-6. (Pubitemid 36808124)
5. Moore WC, Bleecker ER, Curran-Everett D, et al For the National Heart, Lung, and Blood Institute's Severe Asthma Research Program. Characterization of the severe asthma phenotype by the National Heart, Lung, and Blood Institute's Severe Asthma Research Program. J Allergy Clin Immunol 2007;119:405-13. (Pubitemid 46210080)
6. Evans DJ, Cullinan P, Geddes DM, et al. Cyclosporin as an oral corticosteroid sparing agent in stable asthma. Cochrane Airways Group 2001;2:CD002993. doi:10.1002/14651858.CD002993
7. Davies HRH R, Olson LLG, Gibson PG. Methotrexate as a steroid sparing agent for asthma in adults. Cochrane Airways Group. Published Online First: 21 January 2009. doi:10.1002/14651858.CD000391